The potential protective role of coenzyme q10 on the cyclophosphamide-induced lung toxicity in adult male albino rats: a histological and ultrastructural study
Keywords:Cyclophosphamide, Coenzyme Q10, Lung toxicity, SOD, MDA
Background: Cyclophosphamide is anticancer and immunosuppressant agent used to treat malignant and autoimmune diseases. Its long-term use causes side effects, as infertility and pulmonary toxicity. Coenzyme Q10; the only synthesized antioxidant in human body, acts as powerful antioxidant, scavenging free radicals, and inhibiting lipid peroxidation. Aim of present study was to examine effect of coenzyme Q10 on blood biochemical profiles, histopathological changes in lungs of adult rats exposed to cyclophosphamide-induced toxicity.
Methods: 36 adult male albino rats divided into four groups; control and three experimental each having 9 rats. First experimental group received coenzyme Q10, second received cyclophosphamide while third group received coenzyme Q10 along with cyclophosphamide. Experiment lasted for 7 days. On 8th day, animals were sacrificed by decapitation. Lung tissue samples were collected for histopathological examination. SOD (superoxide dismutase) and MDA (malondialdehyde) levels were determined and used for statistical analysis.
Results: In coenzyme Q10 treated group, H&E stained sections revealed normal respiratory alveoli. Ultrathin sections revealed normal alveolar septa, pneumocyte and blood capillaries contain erythrocytes. In cyclophosphamide treated group, H&E stained sections revealed peribronchial and interstitial fibrosis. Ultrathin sections revealed alveoli having apparent free lumen with extravasated erythrocytes. Alveolar septa revealed collagen fibrils deposits, and proliferated fibroblasts. In combined coenzyme Q10 and cyclophosphamide treated group, H&E stained sections revealed marked decrease of inter-alveolar tissue thickening. Ultrathin sections revealed destructed alveolar septa with dissociated remnants of collagen fibrils. Blood capillaries appeared wide, containing monocytes and erythrocytes.
Conclusions: Administration of coenzyme Q10 with cyclophosphamide is advised to alleviate cyclophosphamide-induced lung toxicity.
Meotti FC, Forner S, Lima-Garcia JF, Viana AF, Calixto JB. Antagonism of the transient receptor potential ankyrin 1 (TRPA1) attenuates hyperalgesia and urinary bladder over activity in cyclophosphamide-induced haemorrhagic cystitis. Chem Biol Interact. 2013;203(2):440-7.
Patra K, Bose S, Sarkar S, Rakshit J, Jana S, Mukherjee A, Roy A, Mandal DP, Bhattacharjee S. Amelioration of cyclophosphamide induced myelosuppression and oxidative stress by cinnamic acid. Chem Biol Interact. 2012;195(3):231-9.
MacAllister SL, Martin-Brisac N, Lau V, Yang K, O’Brien PJ. Acrolein and chloroacetaldehyde: an examination of the cell and cell-free biomarkers of toxicity. Chem Biol Interact. 2013;202(1):259-66.
Ashry N, Gameil N, Suddek G. Modulation of cyclophosphamide- induced early lung injury by allicin. Pharm Biol. 2013;51(6):806-11.
Suddek G, Ashry N, Gameil N. Thymoquinone attenuates cyclophosphamide-induced pulmonary injury in rats. Inflammopharmacology 2013;21(6):427-35.
Mizuno K, Tanaka M, Nozaki S, Mizuma H, Ataka S, Tahara T, Sugino T, Shirai T, Kajimoto Y, Kuratsune H, et al. Antifatigue effects of coenzyme Q10 during physical fatigue. Nutrition. 2008;24:293-9.
Rogers S. The ESC. Brussels office takes shape. Eur Heart J. 2013;34:2491-7.
Acosta M, Vazquez Fonseca L, Desbats MA, Cerqua C, Zordan R, Trevisson E, Salviati L. Coenzyme Q biosynthesis in health and disease. Biochim Biophys Acta. 2016;1857(8):1079-85.
Lee BJ, Huang YC, Chen SJ, Lin PT. Coenzyme Q10 supplementation reduces oxidative stress and increases antioxidant enzyme activity in patients with coronary artery disease. Nutrition. 2012;28(3):250-5.
Lee BJ, Tseng YF, Yen CH, Lin PT. Effects of coenzyme Q10 supplementation (300 mg/day) on antioxidation and anti-inflammation in coronary artery disease patients during statins therapy: a randomized, placebo-controlled trial. Nutr J. 2013;12(1):142.
Shekelle P, Morton S, Hardy ML. Effect of supplemental antioxidants vita- min C, vitamin E, and coenzyme Q10 for the prevention and treatment of cardiovascular disease. Evid Rep Technol Assess (Summ). 2003;1-3.
Kamzalov S, Sumien N, Forster MJ, Sohal RS. Coenzyme Q intake elevates the mitochondrial and tissue levels of Coenzyme Q and alpha-tocopherol in young mice. J Nutr. 2003;133(10):3175-80.
Bullón P, Román-Malo L, Marín-Aguilar F, Alvarez-Suarez JM, Giampieri F, Battino M, et al. Lipophilic antioxidants prevent lipopolysaccharide-induced mitochondrial dysfunction through mitochondrial biogenesis improvement. Pharmacol Res. 2015;91:1-8.
James AM, Smith RA, Murphy MP. Antioxidant and prooxidant properties of mitochondrial Coenzyme Q. Arch Biochem Biophys. 2004;423(1):47-56.
Bliznakov EG. Cardiovascular diseases, oxidative stress and antioxidants: the decisive role of coenzyme Q10. Cardiovasc Res. 1999;43(1):248-9.
Turunen M, Olsson J, Dallner G. Metabolism and function of coenzyme Q. Biochim Biophys Acta. 2004;1660(1):171-99.
Littarru GP, Tiano L, Belardinelli R, Watts GF. Coenzyme Q(10), endothelial function, and cardiovascular disease. Biofactors. 2011;37(5):366-73.
Kumar A, Kaur H, Devi P, Mohan V. Role of coenzyme Q10 (CoQ10) in cardiac disease, hypertension and Meniere-like syndrome. Pharmacol Ther 2009;124(3):259-68.
Fouad AA, Al-Sultan AI, Refaie SM, Yacoubi MT. Coenzyme Q10 treatment ameliorates acute cisplatin nephrotoxicity in mice. Toxicology 2010;274:49-56.
Ishikawa A, Homma Y. Beneficial effect of ubiquinone, the reduced form of coenzyme Q10, on cyclosporine nephrotoxicity. Int Braz J Urol. 2012;38:230-4.
Song M, Kim H, Lim Y, Jang I. Effects of coenzyme Q10 on the antioxidant system in SD rat exposedto lipopolysaccharide-induced toxicity. Lab Anim Res. 2017;33(1):24-31.
Reynolds ES. The use of lead citrate of high pH as an electron opaque stain in electron microscopy. J Cell Biol. 1963;17:208.
Mahavadi P, Henneke I, Ruppert C, Knudesen L, Venkatesan S, Liebisch G, et al. Altered surfactant homeostasis and alveolar epithelial cell stress in amiodarone-induced lung fibrosis. Toxicological sciences. 2014;142(1):285-97.
Nishikimi M, Roa NA, Yogi K. Biochemi Bioph Res Common. 1972;46:849-54.
Draper HH, Hadley M. Malondialdehyde determination as index of lipid peroxidation. Methods Enzymol. 1990;186:421–31.
Şengüla E, Gelenb V, Gediklic S, Özkanlard S, Gürd C, Çelebia F, et al. The protective effect of quercetin on cyclophosphamide-Induced lung toxicity in rats. Biomed Pharmacother. 2017;92:303-7.
Selman M, King TE, Pardo A. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. ANN Intern Med. 2001;134:136-51.
Ott M, Khoor A, Leventhal J. Pulmonary toxicity in patients receiving low-dose amiodarone. Chest. 2003;123:646-51.
Sharafkhaneh A, Hanania NA, Kim V. Pathogenesis of Emphysema from the Bench to the Bedside. Proc Am Thorac Soc. 2008;5:475-7.
Chakraborty P, Sk U, Murmu N, Das J, Pal S, Bhattacharya S. Modulation of cyclophosphamide-induced cellular toxicity by diphenylmethyl selenocyanate in vivo, an enzymatic study. J Cancer Mol. 2009;4(6):183-9.
Choi J, Jou S, Oh M, Kim Y, Park M, Gil H, et al. The dose of cyclophosphamide for treating paraquat-induced rat lung injury. Korean J Internal Med. 2013;28(4):420-7.
Preiser J. Oxidative stress. JPEN J Parenter Enteral Nutr. 2012;36(2):147-54.
Sime PJ, O’Reilly KM. Fibrosis of the lung and other tissues: new concepts in pathogenesis and treatment. Clin Immunol. 2001;99:308-19.
Gokce M, Saydam O, Hanci V, Can M, Bahadir B. Antioxidant vitamins C, E and coenzyme Q10 vs dexamethasone: comparisons of their effects in pulmonary contusion model. Journal of Cardiothoracic Surgery 2012;7:92.
Lim H, Jayaweera S, Calderone A, Pepe S, Franklin L, Fuseler J, et al. Tumor necrosis factor-alpha in ischemia and reperfusion injury in rats lung. J Appl Physiol. 2010;85:2005-11.
Khimenko P, Bagby G, Fuseler J, Taylor A. Tumor necrosis factor- alpha in ischemia and reperfusion injury in rats lung. J Appl Physiol. 1998;85:2005-11.
Kant S, Swat W, Zhang S, Zhang Z, Neel BG, Flavell RA, et al. TNF-stimulated MAP kinase activation mediated by a Rho family GTPase signiling pathway. Genes & Dev. 2011;25:2069-78.
Bhagavan HN, Chopra RK. Plasma coenzyme Q10 response to oral ingestion of coenzyme Q10 formulations. Mitochondrion. 2007;7:78-88.